Sonendo, Inc. (SONX) stock
SONXOTCDental Equipment & SuppliesFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Mar 26, 2025
$1.28+0.00 (0.00%)
Close on Oct 19, 2026Market cap $606.54KP/E –Yield –
Sonendo r&d expenses
Research and development expenses are spending on new products and technology.
Sonendo's R&D Expenses for the twelve months ending Dec 31, 2024 was $6.76M, down 35.3% year over year. For fiscal 2024 it was $6.76M, down 35.3% from the year before. The highest annual figure on record is $20.46M in fiscal 2020.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $6.76M | -35.3% |
| FY2023 | Dec 31, 2023 | $10.44M | -37.8% |
| FY2022 | Dec 31, 2022 | $16.78M | -9.7% |
| FY2021 | Dec 31, 2021 | $18.57M | -9.3% |
| FY2020 | Dec 31, 2020 | $20.46M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $1.41M | -28.1% |
| Q3 FY2024 | Sep 30, 2024 | $1.59M | -43.0% |
| Q2 FY2024 | Jun 30, 2024 | $1.57M | -43.3% |
| Q1 FY2024 | Mar 31, 2024 | $2.19M | -25.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.97M | -45.1% |
| Q3 FY2023 | Sep 30, 2023 | $2.79M | -35.6% |
| Q2 FY2023 | Jun 30, 2023 | $2.76M | -31.2% |
| Q1 FY2023 | Mar 31, 2023 | $2.93M | -39.6% |
| Q4 FY2022 | Dec 31, 2022 | $3.58M | -15.9% |
| Q3 FY2022 | Sep 30, 2022 | $4.33M | -6.6% |
| Q2 FY2022 | Jun 30, 2022 | $4.02M | -13.2% |
| Q1 FY2022 | Mar 31, 2022 | $4.85M | -3.9% |
| Q4 FY2021 | Dec 31, 2021 | $4.26M | -28.0% |
| Q3 FY2021 | Sep 30, 2021 | $4.63M | -5.8% |
| Q2 FY2021 | Jun 30, 2021 | $4.63M | – |
| Q1 FY2021 | Mar 31, 2021 | $5.05M | – |
| Q4 FY2020 | Dec 31, 2020 | $5.91M | – |
| Q3 FY2020 | Sep 30, 2020 | $4.92M | – |
See a number that looks wrong?